lung cancer

Research in Review

Drug Trials Show Promising Results for Lung Cancer Treatment

10/01/2015

JCP Editors

Atezolizumab, a monoclonal antibody developed by Roche that is currently in clinical trails, could be set to change the landscape of lung cancer treatment for physicians and patients. A pair of German investigators...

...

10/01/2015

Journal of Clinical Pathways

Clinical Insights

Advances in the Treatment of Early Stage Non-Small Cell Lung Cancer Using Stereotactic Radiation Therapy

09/30/2015

Brian Edward Lally , MD;

Abstract: Surgery is still the most commonly used treatment for early-stage non-small cell lung cancer (NSCLC). However, many patients with NSCLC have significant comorbidities and are not surgical candidates. Radiation therapy has...

Abstract: Surgery is still the...

09/30/2015

IO Learning

News

Cellular Biomedicine Group Announces Positive Results from CAR-T EGFR Immunotherapy Phase I Clinical Trial for Non-Small Cell Lung Cancer

09/28/2015

SHANGHAI, China and PALO ALTO, Calif., September 28, 2015 /GlobeNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a biomedicine firm engaged in the development of effective stem cell...

SHANGHAI, China and PALO ALTO,...

09/28/2015

IO Learning

Research in Review

What Separates Low-Mortality from High-Mortality Hospitals After Lung Cancer Resection?

09/18/2015

JCP Editors

According to a recent report in the online JAMA Surgery, differences in mortality rates after lung cancer resection at hospitals across the country boil down to one key factor: a difference in failure-to-rescue...

...

09/18/2015

Journal of Clinical Pathways

Research in Review

‚ÄòBasket Study‚Äô Shows Treatment Response in Certain Patients with Advanced Lung Cancer

09/17/2015

Jolynn Tumolo ;

Citations: Hyman DM, Puzanov I, Subbiah V, et al. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations. New Engl J Med. 2015;373:726–736. More than one-third of patients with advanced lung...

...

09/17/2015

Journal of Clinical Pathways

Research in Review

Timeliness, Thoroughness Lacking in Lung Cancer Care

09/16/2015

JCP Editors

Averaging more than 2.5 months, the span of time between initial lesion detection and lung resection in patients with lung cancer is often too long, according to researchers who reviewed hospital records at one...

...

09/16/2015

Journal of Clinical Pathways

News

Alliance HealthCare Services and Dignity Health Bay Area Bring CyberKnife Cancer Treatment to Saint Francis Memorial Hospital

06/16/2015

San Francisco CyberKnife treatment center to offer radiation therapy for Northern California patientsJune 16, 2015 08:00 AM Eastern Daylight Time: NEWPORT BEACH, Calif. & SAN FRANCISCO--(BUSINESS WIRE)--Alliance Oncology, a division of...

San Francisco CyberKnife...

06/16/2015

IO Learning

News

Stereotactic Ablative Radiotherapy Achieves Better Overall Survival Than Surgery for Early Lung Cancer

05/14/2015

First randomized clinical trial comparing the two therapies suggests that the non-invasive SABR treatment should be considered an alternative to surgery, especially for elderly patients and those with comorbiditiesMay 13, 2015 - Newswise —...

First randomized clinical trial...

05/14/2015

IO Learning

News

Medical Nanoparticles: Local Treatment of Lung Cancer

03/10/2015

 Neuherberg, Germany, 2 March 2015. Nanoparticles can function as carriers for medicines to combat lung cancer: Working in a joint project at the NIM (Nanosystems Initiative Munich) Excellence Cluster, scientists from the Helmholtz...

 Neuherberg, Germany, 2...

03/10/2015

IO Learning

Clinical Insights

Ablation for Lung Tumors: An Interview With Constantinos T. Sofocleous, MD, PhD

03/05/2015

Jennifer Ford ;

Editor's note: View video of this interview here.At the 2015 Symposium on Clinical Interventional Oncology, part of the International Symposium on Endovascular Therapy, Constantinos T. Sofocleous, MD, PhD, of the Memorial Sloan Kettering...

Editor's note: View video of...

03/05/2015

IO Learning